Jacques Rachelle Suzanne 4

What Happened

• Jacques Rachelle Suzanne, a director of Corbus Pharmaceuticals Holdings, Inc. (CRBP), was granted equity awards on May 19, 2026. The Form 4 reports (1) 3,800 restricted stock units (RSUs) granted at $0.00 and (2) 12,300 derivative awards recorded at $0.00. No cash changed hands for these grants at grant date (reported value $0).

Key Details

• Transaction date: 2026-05-19; filing date: 2026-05-21.
• Reported prices: $0.00 per share for both entries (standard for grants/awards).
• Vesting: the 3,800 RSUs will vest 100% on the one-year anniversary of the grant (May 19, 2027). Footnotes state the 12,300 amount includes 8,600 unvested RSUs previously reported, and an option award (per plan terms) will vest 100% on the one-year anniversary.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Timeliness: Filed two days after the grant date (appears to be within the typical 2-business-day Form 4 reporting window).

Context

• These are awards/grants (not open-market purchases or sales). RSUs and option awards are common compensation and typically vest over time; they do not represent immediate buying or selling of stock. For retail investors, such awards indicate future potential share issuance/dilution if and when they vest and are settled, but they do not, by themselves, signal an immediate insider purchase or sale.